LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00066667
 63.99 84.90 6058 8212 0.7377 0.9098
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 63.99 84.90 1226 8212 0.1493 0.4990
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 63.99 84.90 5983 8212 0.7285 0.9062
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 65.70 84.90 1304 8484 0.1537 0.5087
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 65.70 84.90 6195 8484 0.7302 0.9075
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 65.70 84.90 1239 8484 0.1460 0.4971
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 65.70 84.90 6196 8484 0.7303 0.9076
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 67.41 84.90 1357 8766 0.1548 0.5133
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 67.41 84.90 6434 8766 0.7339 0.9096
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 67.41 84.90 1356 8766 0.1547 0.5131
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 67.41 84.90 6437 8766 0.7343 0.9098
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 69.11 84.90 1277 8988 0.1421 0.4964
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 69.11 84.90 6684 8988 0.7437 0.9138
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 69.11 84.90 1391 8988 0.1548 0.5155
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 69.11 84.90 6671 8988 0.7422 0.9133
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 70.81 84.90 1370 9132 0.1500 0.5100
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 70.81 84.90 6922 9132 0.7580 0.9196
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 70.81 84.90 1453 9132 0.1591 0.5232
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 70.81 84.90 6878 9132 0.7532 0.9177
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 72.52 84.90 1483 9214 0.1609 0.5265
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 72.52 84.90 7042 9214 0.7642 0.9220
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 72.52 84.90 1465 9214 0.1590 0.5238
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 72.52 84.90 7028 9214 0.7627 0.9215
MN20160318_Q02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 74.22 84.90 1421 9343 0.1521 0.5151
MN20160318_Q02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 74.22 84.90 7235 9343 0.7743 0.9260
MN20160318_Q02
C19